Leading traditional therapy areas in the U.S. by MAPD spending PMPY 2016
This statistic shows the leading traditional therapeutic classes by Medicare Advantage Prescription Drug (MAPD) per-member-per-year spending in 2016. Diabetes was the most costly therapy area for which MAPD plans had to spend around 353 U.S. dollars per member and year.